Search research articles
Contact Us
Filters
Showing results (11-20 of 102) with videos related to
Page
of 11
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
May 23, 2013
[Osteolytic processes in bone SPECT-CT in a patient with anorexia nervosa for decades]
B Schröttner, C Gstettner, R Aigner
Journal of Chromatographic Science
|
August 1, 1976
Separation of drug substances by modern liquid chromatography on silver impregnated silica gels
R Aigner, H Spitzy, R W Frei
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 17, 1998
Abdominal stop flow infusion breaks drug resistance in systemically pretreated progressive FIGO IIIc and IV ovarian cancer
K R Aigner, S Gailhofer, C Brammer
Advances in Experimental Medicine and Biology
|
January 1, 1988
Inhibition of proteases during extracorporeal extremity perfusion experimental and clinical results
H Walther, H Müller, K R Aigner
Infusionstherapie (Basel, Switzerland)
|
June 1, 1989
[The course of blood glucose and electrolyte status in parenteral nutrition with a complete solution following intestinal resection]
H Walther, H Müller, K R Aigner
International Journal of Surgery Case Reports
|
January 5, 2021
Tumor response and the quality of life after isolated hypoxic pelvic perfusion for advanced G3 cervical cancer: A case series
Karl R Aigner, Youri Lavinski, Sabine Gailhofer
Unfallchirurgie
|
August 1, 1990
[Splenic rupture following arthroscopy]
H Walther, M Turba, K R Aigner
Cancer Treatment and Research
|
January 1, 1991
Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer
K R Aigner, F Benthin, H Müller
International Journal of Surgery Case Reports
|
September 12, 2020
Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
Karl R Aigner, Emir Selak, Kornelia Aigner
Molecular and Clinical Oncology
|
May 13, 2021
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
Karl R Aigner, Sabine Gailhofer, Kornelia Aigner
Page
of 11
Search research articles
Search
Showing results (11-20 of 102) with videos related to
Sort By:
Page
of 11
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
May 23, 2013
[Osteolytic processes in bone SPECT-CT in a patient with anorexia nervosa for decades]
B Schröttner, C Gstettner, R Aigner
Journal of Chromatographic Science
|
August 1, 1976
Separation of drug substances by modern liquid chromatography on silver impregnated silica gels
R Aigner, H Spitzy, R W Frei
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 17, 1998
Abdominal stop flow infusion breaks drug resistance in systemically pretreated progressive FIGO IIIc and IV ovarian cancer
K R Aigner, S Gailhofer, C Brammer
Advances in Experimental Medicine and Biology
|
January 1, 1988
Inhibition of proteases during extracorporeal extremity perfusion experimental and clinical results
H Walther, H Müller, K R Aigner
Infusionstherapie (Basel, Switzerland)
|
June 1, 1989
[The course of blood glucose and electrolyte status in parenteral nutrition with a complete solution following intestinal resection]
H Walther, H Müller, K R Aigner
International Journal of Surgery Case Reports
|
January 5, 2021
Tumor response and the quality of life after isolated hypoxic pelvic perfusion for advanced G3 cervical cancer: A case series
Karl R Aigner, Youri Lavinski, Sabine Gailhofer
Unfallchirurgie
|
August 1, 1990
[Splenic rupture following arthroscopy]
H Walther, M Turba, K R Aigner
Cancer Treatment and Research
|
January 1, 1991
Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer
K R Aigner, F Benthin, H Müller
International Journal of Surgery Case Reports
|
September 12, 2020
Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
Karl R Aigner, Emir Selak, Kornelia Aigner
Molecular and Clinical Oncology
|
May 13, 2021
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
Karl R Aigner, Sabine Gailhofer, Kornelia Aigner
Page
of 11